01
Clinical care
Appropriately licensed clinicians evaluate the patient and make independent treatment decisions.
Weight and metabolic programs
A GLP-1 program needs an operating model, not a clearance visit.
Scope the licensed clinicians, documented encounters, medical oversight, TrueEHR workflows, pharmacy handoffs, and state-aware requirements around the program you are actually operating.
Program workflow
Configured to scope
01
Patient intake
Program-specific
02
Clinical encounter
Licensed clinician
03
Treatment decision
Independent judgment
04
Follow-up
Protocol + escalation
EHR
Recorded
Rx
When appropriate
QA
Reviewable
Clinical
Licensed care
Operational
Defined handoffs
Technical
TrueEHR workflow
Jurisdictional
State-aware scope
Clinical operating layer
Four parts that have to agree.
The medication may be the product category. The actual system is the clinical workflow around it.
02
Documented workflow
Intake, encounter, consent, prescribing, follow-up, escalation, and chart review are defined for the program.
03
Medication pathway
Prescribing occurs only when permitted and clinically appropriate; pharmacy coordination remains distinct from dispensing.
04
State-aware operations
The workflow is configured around the jurisdictions in scope instead of assuming one nationwide rule.
Responsibility map
Define the boundary before the first patient.
Clear responsibility is more persuasive than an “end-to-end” claim that hides who actually owns each decision.
01Operator
Brand, customer acquisition, commerce, and the commercial relationship.
02TrueEval engagement
The contracted clinical responsibilities, TrueEHR workflows, medical oversight, and clinical operations.
03Treating clinician
Independent medical judgment, treatment decisions, and whether prescribing is appropriate.
04Pharmacy
Compounding or dispensing, product availability, pharmacy licensure, fulfillment, and shipping.
05Independent counsel
Legal advice on entity structure, advertising, contracts, and current jurisdiction-specific requirements.
Buyer questions
The answers should carry their conditions.
What clinical infrastructure can a GLP-1 program require?
The operating model may include appropriately licensed clinicians, a documented clinical encounter, prescribing workflows, medical oversight, chart review, pharmacy coordination, adverse-event processes, and state-specific requirements. The exact scope depends on the program, jurisdiction, medication, patient, and engagement.
Does TrueEval prescribe GLP-1 medications?
TrueEval clinicians may prescribe within their licensure, registration, program protocols, and clinical judgment when legally permitted and clinically appropriate. No medication or prescribing availability is universal or guaranteed.
Does every state use the same visit modality?
No. Modality and encounter requirements can vary by jurisdiction, program, medication, and current law. The engagement is scoped to the states and workflows actually being operated.
How long does onboarding take?
Onboarding runs 3 to 60 days. It is 3 to 7 days when the front end is live, the scope is decided, and LegitScript is not pending; it is closer to 60 days when the funnel still needs to be built or advertising certification is required.
Does TrueEval compound or dispense medication?
No. TrueEval is not the compounding pharmacy. Pharmacy relationships, product availability, dispensing, and shipping are separate responsibilities. TrueEval can coordinate the clinical workflow with an appropriately licensed pharmacy within the engagement.
How is pricing structured?
Pricing is scoped to the engagement, including the states, specialty, visit model, clinical responsibilities, technology, and operating dependencies. You get your quote in writing on the first call, before you sign anything.
Public research
Start with the states in scope.
Explore the public GLP-1 tracker and state resources, then validate current requirements with the relevant primary sources and qualified counsel.
Open the GLP-1 trackerBring the program you intend to operate.
We will map the states, visit model, clinicians, oversight, technology, pharmacy handoffs, and responsibilities that belong in the engagement.
Scope the GLP-1 programRegulatory Information Disclaimer
The telehealth compliance information presented on this page is provided for general informational purposes only and should not be construed as legal advice. The telehealth regulatory landscape is evolving rapidly, with state legislatures, medical boards, and federal agencies frequently updating rules, guidance, and enforcement priorities. While TrueEval makes every effort to keep this information current and accurate, we cannot guarantee that all details reflect the very latest regulatory changes at the time of your visit.
We strongly recommend consulting with a qualified healthcare attorney or compliance professional before making business decisions based on this information. For the most current regulatory requirements, refer directly to your state medical board and relevant licensing authorities. Last reviewed: February 2026.